Related Experiment Video
Updated: Jun 20, 2026
04:09
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Regenerative medicine for diabetes mellitus
Naoya Kobayashi1, Takeshi Yuasa, Teru Okitsu
1Department of Gastroenterological Surgery, Transplant and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. immortal@md.okayama-u.ac.jp
Cell Transplantation
|September 25, 2009
Summary
Regenerating pancreatic beta-cells is key for treating diabetes. Advances in regenerative medicine offer new hope for restoring insulin production and improving diabetes outcomes.
Area of Science:
- Endocrinology
- Regenerative Medicine
- Cell Biology
Background:
- Diabetes mellitus is characterized by a loss of pancreatic beta-cells, leading to insulin dependency.
- This beta-cell loss is a hallmark of type 1 diabetes and also contributes to the pathology of type 2 diabetes, involving insulin resistance and secretory failure.
- Current treatments aim to manage insulin levels, but definitive treatment requires restoring functional beta-cell mass.
Purpose of the Study:
- To explore the potential of pancreatic beta-cell regeneration for definitive diabetes treatment.
- To review existing and potential methods for generating functional pancreatic beta-cells.
- To highlight the significance of regenerative medicine in addressing beta-cell loss across different diabetes types.
Main Methods:
- Review of in vitro beta-cell generation and transplantation strategies.
- Analysis of in vivo regeneration approaches, including gene therapy and differential proliferation factors.
- Examination of the role of beta-cell mass in type 2 diabetes pathophysiology.
Main Results:
- Established methods for generating pancreatic beta-cells in vitro for transplantation.
- Emerging strategies for in vivo beta-cell regeneration through genetic or biochemical stimulation.
- Evidence suggesting that beta-cell regeneration could ameliorate type 2 diabetes pathology.
Conclusions:
- Pancreatic beta-cell regeneration is a critical goal for achieving a definitive cure for diabetes.
- Both in vitro and in vivo regenerative approaches hold promise for restoring beta-cell function.
- The development of beta-cell-targeting regenerative medicine represents a significant advancement in diabetes therapeutics.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.